Shire Plc Offices As AbbVie Inc. Considers Ending $51.5 Billion Deal On Tax Rule

A Shire Plc logo sits on a wall outside the company's offices at the Citywest Business Campus in Dublin, Ireland, on Wednesday, Oct. 15, 2014. AbbVie Inc. is considering scrapping the planned 32.4-billion-pound ($51.5 billion) acquisition of Dublin-based drugmaker Shire in what would be the biggest casualty of the U.S. crackdown on so-called tax inversions. Photographer: Aidan Crawley/Bloomberg via Getty Images
A Shire Plc logo sits on a wall outside the company's offices at the Citywest Business Campus in Dublin, Ireland, on Wednesday, Oct. 15, 2014. AbbVie Inc. is considering scrapping the planned 32.4-billion-pound ($51.5 billion) acquisition of Dublin-based drugmaker Shire in what would be the biggest casualty of the U.S. crackdown on so-called tax inversions. Photographer: Aidan Crawley/Bloomberg via Getty Images
Shire Plc Offices As AbbVie Inc. Considers Ending $51.5 Billion Deal On Tax Rule
PURCHASE A LICENSE
How can I use this image?
kr. 3.000,00
DKK

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Bloomberg / Contributor
Editorial #:
457244854
Collection:
Bloomberg
Date created:
October 15, 2014
Upload date:
License type:
Release info:
Not released. More information
Source:
Bloomberg
Object name:
IRELAND SHIRE PLC
Max file size:
4000 x 2841 px (13.33 x 9.47 in) - 300 dpi - 3 MB